iBio (IBIO) Cash from Investing Activities (2010 - 2026)

iBio (IBIO) has 17 years of Cash from Investing Activities data on file, last reported at -$3.1 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 22121.43% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was -$27.5 million, a 5080.47% decrease from a year earlier, with the FY2025 full-year figure at $742000.0, down 18.1% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$3.1 million, down from -$3.0 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for IBIO reached as high as $8.2 million in Q1 2023 and fell as low as -$21.5 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$1.1 million across 5 years, with a median of $13500.0 in 2022.
• Across the five-year window, Cash from Investing Activities surged 1494.0% in 2023 and tumbled 149050.0% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$1.3 million in 2022, then jumped by 103.98% to $50000.0 in 2023, then plunged by 104.0% to -$2000.0 in 2024, then tumbled by 149050.0% to -$3.0 million in 2025, then decreased by 4.29% to -$3.1 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$3.1 million in Q1 2026, -$3.0 million in Q4 2025, and -$21.5 million in Q3 2025.